APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 281 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $309,740 | +38.1% | 3,400 | 0.0% | 0.02% | +23.5% |
Q1 2023 | $224,264 | -17.9% | 3,400 | -15.0% | 0.02% | -34.6% |
Q3 2022 | $273,000 | +20.8% | 4,000 | -20.0% | 0.03% | +23.8% |
Q2 2022 | $226,000 | -1.3% | 5,000 | +25.0% | 0.02% | -12.5% |
Q4 2020 | $229,000 | – | 4,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |